FDA Inspection 1247921 — Ochsner Lafayette General Medical Center Dept. of Pathology-Blood Bank

Ochsner Lafayette General Medical Center Dept. of Pathology-Blood Bank — FEI 2377794

The FDA completed an inspection of Ochsner Lafayette General Medical Center Dept. of Pathology-Blood Bank on July 12, 2024 in Lafayette, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 12, 2024
Fiscal Year
2024
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Lafayette, LA (United States)